Search results
AbbVie to pay up to $2.37 billion to settle U.S. opioid claims
Reuters via Yahoo News· 2 years ago(Reuters) -AbbVie Inc has agreed to pay up to $2.37 billion to resolve thousands of U.S. lawsuits...
AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
Reuters via Yahoo Finance· 2 years agoThe deal would settle more than 3,000 lawsuits filed by state and local governments, but complete...
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Benzinga via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc (NYSE: ABBV) have finalized the...
2 Dividend Stocks to Double Up On Right Now
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) and GlaxoSmithKline (NYSE: GSK) have much in common. They are huge pharmaceutical companies that have a long record of success,...
Better Buy: Johnson & Johnson or AbbVie?
Motley Fool· 1 year agoJohnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV) are two of the bigger names in healthcare stocks. The companies are favored by income-oriented...
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements
Reuters via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Ltd and AbbVie Inc have finalized the terms of settlements worth more...
Better Dividend Stock: AbbVie vs. Johnson & Johnson
Motley Fool· 1 year agoThe pharmaceutical industry is a great place to look for dividend stocks, and AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) are among the best....
Allergan reaches tentative $2.37 billion settlement on opioid marketing lawsuits
The Hill via Yahoo News· 2 years agoDrugmaker AbbVie on Friday said it has agreed in principle to pay more than $2 billion to settle...
UPDATE 1-AbbVie sets aside $2 billion to settle U.S. opioid claims
Reuters via Yahoo Finance· 2 years agoAbbVie Inc has set aside about $2 billion to resolve thousands of lawsuits against its Allergan unit over the marketing of its opioid products, the company said on Friday. AbbVie faces more ...
AbbVie Says BeiGene's Flagship Blood Cancer Drug Infringes Imbruvica Patent
Benzinga via Yahoo Finance· 10 months agoBeiGene Ltd (NASDAQ: BGNE) says it is aware that Pharmacyclics LLC has filed a complaint alleging...
